|
WO2014026271A1
|
|
Surface chemical gradients
|
|
WO2013185207A1
|
|
Fullerenes with substituted indene-based groups
|
|
WO2013177705A1
|
|
Genotyping assay for identifying chromosomal rearrangements
|
|
WO2013155606A1
|
|
Method for b0 field correction in magnetic resonance
|
|
WO2013123591A1
|
|
Multimerized single domain antibody ligands of prothrombin as inhibitors of blood and extravascular coagulation
|
|
WO2013120190A1
|
|
Centrifugal microfluidic mixing apparatus and method
|
|
DE102012221749A1
|
|
Phase-selective geling with compounds of alkylated aromatic acid
|
|
CA2793268A1
|
|
Method and apparatus for paraphrase acquisition
|
|
WO2013044352A1
|
|
Method of fabricating nano-tips with controlled profile
|
|
WO2013029153A1
|
|
Centrifugally-enhanced capture method and device
|
|
CA2784572A1
|
|
Process mining for anomalous cases
|
|
WO2013010252A1
|
|
Photobioreactor
|
|
CA2780831A1
|
|
Method for fabrication of metal oxide nanoparticles
|
|
CA2778722A1
|
|
Flow control of combustible mixture into combustion chamber
|
|
CA2833614A1
|
|
Locally-active anticoagulants and anti-inflammatory agents
|
|
CA2840126A1
|
|
Centrifugal microfluidic platform
|
|
WO2012122628A1
|
|
Microfluidic system having monolithic nanoplasmonic structures
|
|
WO2012122626A1
|
|
Prognostic marker sets for prostate cancer
|
|
CA2764619A1
|
|
Biological tissue inspection method and system
|
|
WO2012097435A1
|
|
Immunoreactive francisella tularensis antigens
|
